RhumbLine Advisers
PRVL

RhumbLine Advisers’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

RhumbLine Advisers’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$352K Buy
2020
Q3 		$145K Sell
2020
Q2 		$224K Buy